Clinical Trials on Neurodegeneration in Australia

Total 470 results

Actinogen Medical
Avance Clinical

Completed

A Double-Blind, Placebo-Controlled, Dose Ranging Study of Xanamem® in Healthy Elderly Volunteers (XanaMIA-DR)

Mild Cognitive Impairment | Alzheimer's Disease

Australia
University of South Australia
Flinders University

Recruiting

Small Steps Towards Improving Activity and Sleep Habits to Decrease the Risk of Dementia

Dementia | Alzheimer Disease

Australia
SciNeuro

Completed

A First Time in Human Study of SNP318 as a Treatment for Neurodegenerative Diseases Including Alzheimer's Disease

Neurodegenerative Diseases | Alzheimer's Disease

Australia
Cerecin

Terminated

Tricaprilin Liquid Formulation PK Study

Alzheimer Disease

Australia
Lyndra Inc.

Completed

Study to Evaluate Safety/Duration in Stomach of Extended Release Capsules Containing Memantine Hydrochloride in Healthy Adults

Healthy | Alzheimer Disease | Gastric Retention

Australia
Luye Pharma Group Ltd.

Enrolling by invitation

to Evaluate the Safety, Tolerability and Pharmacokinetics of Four Formulations of LY03009 in Healthy Volunteers

Parkinson's Disease

Australia
The University of Western Australia

Completed

Randomised Crossover Trial of DBS of Differential PSA Regions in Parkinson's Disease and Tremor

Parkinson's Disease | Tremor

Australia
Inventage Lab., Inc.

Recruiting

A Clinical Trial to Access Pharmacokinetic Profiles and Safety of IVL3003.

Alzheimer Disease

Australia
Seelos Therapeutics, Inc.

Withdrawn

SLS-005 (Trehalose Injection) in the Treatment of Alzheimer's Disease ([STRIVE-AD])

Alzheimer's Disease

Australia
Anavex Life Sciences Corp.

Completed

An Extension Study of ANAVEX2-73 in Patients With Mild to Moderate Alzheimer's Disease

Alzheimer's Disease

Australia
Anavex Life Sciences Corp.

Completed

Phase 2a Dose Finding, PK/PD and 12 Month Exploratory Efficacy Study of ANAVEX2-73 in Patients With Alzheimer's Disease (ANAVEX)

Alzheimer's Disease

Australia
Asceneuron Pty Ltd.
Neuroscience Trials Australia; Asceneuron S.A.

Terminated

Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of Oral ASN51 in Healthy Subjects and Subjects With Alzheimer's Disease

Alzheimer Disease

Australia
Cerecin

Completed

Pharmacokinetics of Tricaprilin Including Food Effect on Ketone Body Production

Alzheimer Disease

Australia
Cerecin

Completed

AC-OLE-01-VA Tolerability Study in Healthy Participants Under Different Dosing Conditions

Alzheimer Disease

Australia
Cerecin

Completed

Study to Compare the Pharmacokinetics of Tricaprilin Formulations and a Placebo on Ketone Body Production

Alzheimer Disease

Australia
VTBIO Co. LTD
BHT Lifescience Austrailia Pty Ltd.

Unknown

A Safety and Tolerability Study of GB301

Alzheimer Disease

Australia
The University of Western Australia
Sir Charles Gairdner Hospital; Perron Institute for Neurological and Translational...

Withdrawn

Optimising Anterior Pallidal Deep Brain Stimulation for Tourette's Syndrome

Tourette's Syndrome

Australia
Austin Health

Unknown

Sensory Cues for Freezing in Parkinson's Disease

Parkinson's Disease

Australia
Monash University
University of Melbourne; Wake Forest University; Invitae Corporation; Eastern Health and other collaborators

Recruiting

Neurofilament Light Chain And Voice Acoustic Analyses In Dementia Diagnosis (NAVAIDD)

Neurodegenerative Diseases | Dementia

Australia
Cyto Therapeutics Pty Limited

Unknown

A Study to Evaluate the Safety of Neural Stem Cells in Patients With Parkinson's Disease

Parkinson Disease

Australia
Austin Health

Unknown

Assessing the Role of Exercise Intensity in Slowing Disease Progression in Early Parkinson's Disease

Parkinson's Disease

Australia
Bayside Health

Completed

Impact of a Memory Group for Older Adults Reporting Memory Difficulties

Mild Cognitive Impairment | Alzheimer's Disease

Australia
Atridia Pty Ltd.

Completed

A Trial of SHR-1707 in Healthy Young Adult and Elderly Subjects

Alzheimer Disease

Australia
GlaxoSmithKline

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single, Oral Escalating Doses of GSK2647544 in Healthy Volunteers

Alzheimer's Disease

Australia
University of Tasmania
National Health and Medical Research Council, Australia; University of Leeds; University of Sydney

Recruiting

TAS Test: Online Motor-cognitive Tests for Early Detection of Alzheimer's Disease (TASTest)

Dementia | Alzheimer Disease | Age-related Cognitive Decline

Australia
Inmune Bio, Inc.
Alzheimer's Association

Completed

A Biomarker-directed Study of XPro1595 in Patients With Alzheimer's

Alzheimer Disease

Australia
Impel Pharmaceuticals

Completed

Therapeutic Potential for Intranasal Levodopa in Parkinson's Disease -Off Reversal (THOR201)

Parkinson's Disease

Australia
GlaxoSmithKline

Completed

A Clinical Study to Assess Single and Repeat Doses of a New Medication (GSK933776) in Patients With Alzheimer's Disease

Alzheimer's Disease

Australia, Sweden, Norway
Implicit Bioscience

Withdrawn

IC14 for Rapidly Progressive Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis

Australia
Implicit Bioscience

Withdrawn

IC14 for Treatment of Amyotrophic Lateral Sclerosis

Motor Neuron Disease | Amyotrophic Lateral Sclerosis

Australia
Implicit Bioscience
Royal Brisbane and Women's Hospital

Completed

Dose-Escalation, Safety and Pharmacokinetic Study of IC14 in Motor Neurone Disease

Motor Neuron Disease | Amyotrophic Lateral Sclerosis

Australia
The University of Queensland

Completed

The Effect of a Wearable Cueing Device on Freezing of Gait in Parkinson's Disease (CuePed)

Gait Disorders, Neurologic

Australia
The Florey Institute of Neuroscience and Mental...
The University of Queensland; Mobius Medical Pty Ltd.

Recruiting

A Double-blind Randomised, Placebo-controlled Clinical Trial to Test Ambroxol Treatment in ALS (AMBALS)

Amyotrophic Lateral Sclerosis

Australia
Inmune Bio, Inc.

Recruiting

An Open-Label Extension of XPro1595 in Patients With Alzheimer's Disease

Mental Disorders | Brain Diseases | Central Nervous System Diseases | Nervous System Diseases | Neurocognitive Disorders | Neurodegenerative Diseases | Dementia | Alzheimer Disease | Tauopathies

Australia, Canada
Neuroscience Research Australia
Michael J. Fox Foundation for Parkinson's Research; Shake it up Australia Foundation and other collaborators

Completed

The WalkingTall Study: Comparing WalkingTall With Parkinson's Disease (WalkingTall-PD) With Mobility-plus to Reduce Falls and Improve Mobility. (WalkingTall-PD)

Parkinson Disease

Australia
Life Molecular Imaging SA

Completed

Florbetaben (BAY94-9172) PET (Positron Emission Tomography) Imaging in MCI (Mild Cognitive Impairment) Patients

Alzheimer Disease | Amyloid Beta-Protein

Australia
Cognition Therapeutics

Completed

Clinical Trial of CT1812 in Mild to Moderate Alzheimer's Disease

Alzheimer's Disease

Australia
Avid Radiopharmaceuticals

Completed

Florbetapir Calibration to the Centiloid Scale

Alzheimer's Disease

United States, Australia
Actinogen Medical

Recruiting

Effect of 10 mg Xanamem on Dementia Due to Alzheimer's Disease (XanaMIA)

Alzheimer Disease | Dementia, Mild | Dementia Moderate

Australia
Janssen-Cilag Pty Ltd

Completed

An Observational Study of the Safety and Effectiveness of Galantamine in the Treatment of Patients With Alzheimer's Disease Over an 18-month Period

Dementia | Alzheimer Disease | Galantamine

Australia
The University of Queensland
Johns Hopkins University; Royal Brisbane and Women's Hospital; Queensland University... and other collaborators

Recruiting

Uncovering a Novel Therapeutic Target to Reduce Dementia Risk in Parkinson's Disease (TRIP)

Parkinson Disease | Mild Cognitive Impairment | Memory Impairment

Australia
University of Tasmania

Enrolling by invitation

TapTalkTest Project:Development of a Non-invasive Screening Test to Detect Risk of Alzheimer's Disease Pathology (TapTalkTest)

Dementia | Alzheimer Disease | Speech Disorders | Movement Abnormalities

Australia
Pfizer

Completed

A Phase I, Single IV Dose Of PF-04360365 In Adults With Mild To Moderate Alzheimer's Disease

Alzheimer's Disease

Canada, United Kingdom, Australia, Sweden
Spinogenix
Novotech (Australia) Pty Limited

Recruiting

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SPG302 in Healthy Volunteers and ALS Participants

Amyotrophic Lateral Sclerosis

Australia
University of Manitoba

Unknown

Investigating the Effect of Repetitive Transcranial Magnetic Stimulation (rTMS) as a Treatment for Alzheimer's Disease

Alzheimer's Disease

Canada, Australia
CuraSen Therapeutics, Inc.

Not yet recruiting

A Study of CST-103 Co-administered With CST-107 in Subjects With Parkinson's Disease Having Freezing of Gait (CLIN-012)

Freezing of Gait Symptoms in Parkinson's Disease

Australia
Natalie Allen
South West Sydney Local Health District

Terminated

Walking Capacity in Parkinson's Disease (PD-Walk)

Idiopathic Parkinson's Disease

Australia
Gold Coast Hospital and Health Service
Bod Australia

Active, not recruiting

EMERALD TRIAL Open Label Extension Study (EMERALD-OLE)

Motor Neuron Disease | Amyotrophic Lateral Sclerosis | Cannabis | CBD

Australia
Gold Coast Hospital and Health Service
Bod Australia

Active, not recruiting

Efficacy of Cannabinoids in Amyotrophic Lateral Sclerosis or Motor Neurone Disease

Motor Neuron Disease | Amyotrophic Lateral Sclerosis

Australia
Collaborative Medicinal Development Pty Limited

Active, not recruiting

ALS Treatment Extension Study

Amyotrophic Lateral Sclerosis

Australia

Clinical Trials on Neurodegeneration in Australia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Singapore

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations